分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

TOR3A represses type I interferon production and limits viral clearance during respiratory syncytial virus infection

Xiaoping Li, Zhengrong Chen, Mengyun Wu, Peijie Zhu, Guodong Qiao, Jiaoyang Li, Yunfei Ye, Jiamin Cai, Ying Zhou, Xiaoqiu Dai, Yufeng Wang, Cancheng Li, Jiaqi Huang, Ji Zhou, Fei Xu, Chensheng Tan, Yu Shao, Xiu Gao, Jingjing Hu, Xuena Xu, Chunsheng Dong, Chuangli Hao, Yi Yang, Jinping Zhang

Journal:Emerging Microbes & Infections

IF:7.5

DOI:10.1080/22221751.2026.2637961

PMID:

Published:2026-03-13

research field:分子生物学免疫学病毒学

Abstract

Type I interferons (IFN-I) are essential for antiviral immunity, and precise regulation of IFN-I production is crucial to balance viral clearance and immunopathology. Here, we demonstrate that the interferon-stimulated gene TOR3A negatively regulates type I IFN signalling during respiratory syncytial virus (RSV) infection. TOR3A expression was upregulated in macrophages and RSV-infected patients, and its deficiency enhanced antiviral responses, leading to reduced viral load. Mechanistically, RSV infection induced TOR3A expression through the IFN-STAT1 pathway, which in turn suppressed IFN-I production. Furthermore, TOR3A recruited the E3 ubiquitin ligase STUB1 to mediate K48-linked ubiquitination and proteasomal degradation of RIG-I at lysine 146, thereby promoting RSV immune evasion. Our study identifies TOR3A as a novel suppressor of antiviral immunity and uncovers a mechanism by which RSV exploits host ISGs to dampen IFN-I responses, providing new insights into viral pathogenesis and potential therapeutic strategies.

本文使用的Yeasen产品

购物车
客服
转染试用